mRNA |
CMK |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
0.0092 |
0.8 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
JW-7-52-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
-0.009 |
0.8 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0084 |
0.8 |
mRNA |
CP724714 |
GDSC1000 |
pan-cancer |
AAC |
0.008 |
0.8 |